News Website

4 chilling details about the Taylor Parker case missing from “Maternal Instinct” - Yahoo

4 chilling details about the Taylor Parker case missing from “Maternal Instinct” Yahoo

Published: June 24, 2026, 10:31 p.m.

Read Full Article

Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t - MedCity News

Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t MedCity News

Published: June 24, 2026, 10:10 p.m.

Read Full Article

Allison Williams Shares Cryptic Response When Asked If There's a Girls Reunion Project in the Works (Exclusive) - People.com

Allison Williams Shares Cryptic Response When Asked If There's a Girls Reunion Project in the Works (Exclusive) People.com

Published: June 24, 2026, 9:42 p.m.

Read Full Article

Absci (NASDAQ: ABSI) prices $100M underwritten equity deal to fund ABS-201 - Stock Titan

Absci (NASDAQ: ABSI) prices $100M underwritten equity deal to fund ABS-201 Stock Titan

Published: June 24, 2026, 8:32 p.m.

Read Full Article

Prime Day beauty deals: Save on my favorite products from Solawave, Drybar, and more - Mashable

Prime Day beauty deals: Save on my favorite products from Solawave, Drybar, and more Mashable

Published: June 24, 2026, 7:24 p.m.

Read Full Article

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) - Seeking Alpha

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) Seeking Alpha

Published: June 24, 2026, 7:18 p.m.

Read Full Article

Quick optical biopsy could be early detection method for endometrial cancer - WashU

Quick optical biopsy could be early detection method for endometrial cancer WashU

Published: June 24, 2026, 6:38 p.m.

Read Full Article

Baylen Out Loud: Baylen Gets Emotional Amidst Baby Making Talks - Fears She Cannot Have Kids! - TV Season & Spoilers -

Baylen Out Loud: Baylen Gets Emotional Amidst Baby Making Talks - Fears She Cannot Have Kids! TV Season & Spoilers -

Published: June 24, 2026, 1:53 p.m.

Read Full Article

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - markets.businessinsider.com

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) markets.businessinsider.com

Published: June 24, 2026, 11:25 a.m.

Read Full Article

Absci stock surges 24% on positive Phase 1 hair loss drug data - Investing.com South Africa

Absci stock surges 24% on positive Phase 1 hair loss drug data Investing.com South Africa

Published: June 24, 2026, 11:14 a.m.

Read Full Article

Latest Articles

4 chilling details about the Taylor Parker case missing from “Maternal Instinct” - Yahoo

Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t - MedCity News

Allison Williams Shares Cryptic Response When Asked If There's a Girls Reunion Project in the Works (Exclusive) - People.com

Absci (NASDAQ: ABSI) prices $100M underwritten equity deal to fund ABS-201 - Stock Titan

Prime Day beauty deals: Save on my favorite products from Solawave, Drybar, and more - Mashable

Exclusive BAC Article: Absci Corporation; Positive Phase 1 Data ABS-201 AGA, Interim And Final POC Data 2nd Half 2026/Early 2027, Respectively, Advancement Endometriosis And Catalysts (NASDAQ:ABSI) - Seeking Alpha

Quick optical biopsy could be early detection method for endometrial cancer - WashU

Baylen Out Loud: Baylen Gets Emotional Amidst Baby Making Talks - Fears She Cannot Have Kids! - TV Season & Spoilers -

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR) - markets.businessinsider.com

Absci stock surges 24% on positive Phase 1 hair loss drug data - Investing.com South Africa

Subscribe to Our Newsletter